OpenURL Connection Search

Select item for more details and to access through your institution.

2268. Clinical Implications of Azole-Resistant vs. Azole-Susceptible Invasive Aspergillosis in Hematological Malignancy (CLARITY): A Multicenter Study.
Published in:
Open Forum Infectious Diseases, 2019, v. 6, p. S776, doi. 10.1093/ofid/ofz360.1946
By:
- Seidel, Danila;
- Cornely, Oliver;
- Arenz, Dorothee;
- Meis, Jacques;
- Vehreschild, Jörg;
- Salmanton-Garcia, Jon;
- Zarrouk, Marouan;
- Romero, Iker Falces;
- Racil, Zdenek;
- Lagrou, Katrien;
- Maertens, Johan;
- Sharpe, Agustìn Reséndiz;
- Blennow, Ola;
- Lass-Flörl, Cornelia;
- Legovic, Yohann;
- Ostojic, Alen;
- Desoubeaux, Guillaume;
- Alakel, Nael;
- Schalk, Enrico;
- Bergeron-Lafaurie, Anne
Publication type:
Article
Slowly or Nonresolving Legionnaires’ Disease: Case Series and Literature Review.
Published in:
Clinical Infectious Diseases, 2020, v. 70, n. 9, p. 1933, doi. 10.1093/cid/ciz538
By:
- Pouderoux, Cécile;
- Ginevra, Christophe;
- Descours, Ghislaine;
- Ranc, Anne-Gaëlle;
- Beraud, Laetitia;
- Boisset, Sandrine;
- Magand, Nicolas;
- Conrad, Anne;
- Bergeron-Lafaurie, Anne;
- Jarraud, Sophie;
- Ader, Florence
Publication type:
Article
DC-SIGN Induction in Alveolar Macrophages Defines Privileged Target Host Cells for Mycobacteria in Patients with Tuberculosis.
Published in:
PLoS Medicine, 2005, v. 2, n. 12, p. e381, doi. 10.1371/journal.pmed.0020381
By:
- Tailleux, Ludovic;
- Nhan Pham-Thi;
- Bergeron-Lafaurie, Anne;
- Herrmann, Jean-Louis;
- Charles, Patricia;
- Schwartz, Olivier;
- Scheinmann, Pierre;
- Lagrange, Philippe H.;
- De Blic, Jacques;
- Tazi, Abdellatif;
- Gicquel, Brigitte;
- Neyrolles, Olivier
Publication type:
Article

Found: 3

2268. Clinical Implications of Azole-Resistant vs. Azole-Susceptible Invasive Aspergillosis in Hematological Malignancy (CLARITY): A Multicenter Study.

Slowly or Nonresolving Legionnaires’ Disease: Case Series and Literature Review.

DC-SIGN Induction in Alveolar Macrophages Defines Privileged Target Host Cells for Mycobacteria in Patients with Tuberculosis.